Q2 2020 Dare Bioscience Inc Earnings Call Transcript
Welcome to the conference call hosted by Daré Bioscience to review the company's financial results for the quarter ended June 30, 2020, and to provide a general business update. This call is being recorded. My name is Chris, and I'll be your operator today.
With us today are Sabrina Martucci Johnson, Dare's President and Chief Executive Officer; John Fair, Dare's Chief Strategy Officer; and Lisa Walters-Hoffert, Dare's Chief Financial Officer.
Ms. Johnson, please proceed.
© -
Thank you. Welcome to our financial results and business update call for Daré Bioscience. We're looking forward to discussing our second quarter results and highlighting recent developments and anticipated milestones for the remainder of 2020 and beyond.
Before we begin, I'd like to remind you that today's discussion will include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |